BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiore FD, Lecleire S, Rigal O, Galais MP, Soussan EB, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12(26): 4185-4190 [PMID: 16830371 DOI: 10.3748/wjg.v12.i26.4185] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Lecleire S, Antonietti M, Iwanicki-Caron I, Duclos A, Lemoine F, Pessot FL, Michel P, Ducrotté P, Di Fiore F. Lugol chromo-endoscopy versus narrow band imaging for endoscopic screening of esophageal squamous-cell carcinoma in patients with a history of cured esophageal cancer: a feasibility study. Dis Esophagus. 2011;24:418-422. [PMID: 21309914 DOI: 10.1111/j.1442-2050.2010.01164.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
2 Bauer J, Jürgens H, Frühwald MC. Important aspects of nutrition in children with cancer. Adv Nutr 2011;2:67-77. [PMID: 22332035 DOI: 10.3945/an.110.000141] [Cited by in Crossref: 122] [Cited by in F6Publishing: 100] [Article Influence: 11.1] [Reference Citation Analysis]
3 Movahed S, Norouzy A, Ghanbari-Motlagh A, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, Nematy M, Ghayour-Mobarhan M, Varshoee Tabrizi F, Bozzetti F, Seilanian Toussi M. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev 2020;21:2315-23. [PMID: 32856860 DOI: 10.31557/APJCP.2020.21.8.2315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer 2008;99:1586-92. [PMID: 19002180 DOI: 10.1038/sj.bjc.6604749] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 5.1] [Reference Citation Analysis]
5 Ma HF, Lv GX, Cai ZF, Zhang DH. Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis. Onco Targets Ther 2018;11:3441-7. [PMID: 29942136 DOI: 10.2147/OTT.S145063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
6 Huang Y, Wang H, Luo G, Zhang Y, Wang L, Li K. A systematic review and network meta-analysis of neoadjuvant therapy combined with surgery for patients with resectable esophageal squamous cell carcinoma. Int J Surg 2017;38:41-7. [PMID: 28027995 DOI: 10.1016/j.ijsu.2016.12.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
7 Li M, Zhang X, Zhao F, Luo Y, Kong L, Yu J. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. Radiat Oncol 2016;11:18. [PMID: 26846932 DOI: 10.1186/s13014-016-0589-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
8 Zhang W, Luo Y, Wang X, Han G, Wang P, Yuan W, Dai SB. Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy. Cancer Manag Res 2018;10:2675-82. [PMID: 30147366 DOI: 10.2147/CMAR.S160909] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Qu XM, Biagi JJ, Hopman WM, Mahmud A. Shifting practice in definitive chemoradiation for localized esophageal cancer. Curr Oncol 2017;24:e379-87. [PMID: 29089808 DOI: 10.3747/co.24.3677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Skipworth J, Foster J, Raptis D, Hughes F. The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma. Dis Esophagus 2009;22:559-63. [PMID: 19222536 DOI: 10.1111/j.1442-2050.2009.00939.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
11 Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007;102:2557-63. [PMID: 17680847 DOI: 10.1111/j.1572-0241.2007.01437.x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 7.7] [Reference Citation Analysis]
12 Ferrat E, Paillaud E, Laurent M, Le Thuaut A, Caillet P, Tournigand C, Lagrange JL, Canouï-Poitrine F, Bastuji-Garin S; ELPACA Study Group. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. J Gerontol A Biol Sci Med Sci 2015;70:1148-55. [PMID: 25834194 DOI: 10.1093/gerona/glv025] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 9.6] [Reference Citation Analysis]
13 Lecleire S, Di Fiore F, Antonietti M, Ben-Soussan E, Hochain P, Lerebours E, Michel P, Ducrotté P. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent. Am J Gastroenterol 2008;103:2215-9. [PMID: 18844614 DOI: 10.1111/j.1572-0241.2008.02042.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
14 Yang H, Xu L, Qian H, Niu X, Zhao D, Zhao Z, Wu J, Liu J, Wang Y. Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma. Mol Med Rep 2016;13:4143-50. [PMID: 27035126 DOI: 10.3892/mmr.2016.5046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Uchinami Y, Myojin M, Takahashi H, Harada K, Shimizu S, Hosokawa M. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. Radiat Oncol 2016;11:84. [PMID: 27328734 DOI: 10.1186/s13014-016-0660-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 Piessen G, Messager M, Mirabel X, Briez N, Robb WB, Adenis A, Mariette C. Is There a Role for Surgery for Patients with a Complete Clinical Response after Chemoradiation for Esophageal Cancer? An Intention-to-Treat Case-Control Study. Annals of Surgery 2013;258:793-800. [DOI: 10.1097/sla.0000000000000228] [Cited by in Crossref: 51] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
17 Zingg U, Divalentino D, McQuinn A, Mardzuki A, Thompson SK, Karapetis CS, Watson DI. Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer. Clin Exp Gastroenterol 2009;2:75-83. [PMID: 21694830 DOI: 10.2147/ceg.s6273] [Reference Citation Analysis]
18 Prevost V, Joubert C, Heutte N, Babin E. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:113-20. [PMID: 24657191 DOI: 10.1016/j.anorl.2013.06.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
19 Aaldriks A, Maartense E, le Cessie S, Giltay E, Verlaan H, van der Geest L, Kloosterman-boele W, Peters-dijkshoorn M, Blansjaar B, van Schaick H, Nortier J. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Critical Reviews in Oncology/Hematology 2011;79:205-12. [DOI: 10.1016/j.critrevonc.2010.05.009] [Cited by in Crossref: 116] [Cited by in F6Publishing: 93] [Article Influence: 10.5] [Reference Citation Analysis]
20 Nam SY, Jeon SW, Lee SJ, Kwon YH, Lee HS, Kim SK. Clinical Factors to Predict the Response to Concurrent Chemoradiotherapy and Survival in Esophageal Cancer Patients. Gut Liver 2020;14:450-8. [PMID: 32000467 DOI: 10.5009/gnl19165] [Reference Citation Analysis]
21 Piessen G, Briez N, Triboulet J, Mariette C. Patients with Locally Advanced Esophageal Carcinoma Nonresponder to Radiochemotherapy: Who Will Benefit From Surgery? Ann Surg Oncol 2007;14:2036-44. [DOI: 10.1245/s10434-007-9405-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
22 Yu X, Yang J, Chen T, Liu Y, Xue W, Wang M, Bai S. Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant Chemotherapy. Canadian Journal of Gastroenterology and Hepatology 2018;2018:1-8. [DOI: 10.1155/2018/6075207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Shin HJ, Moon HS, Kang SH, Sung JK, Jeong HY, Kim SH, Lee BS, Kim JS, Yun GY. Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma: Is it a significant prognostic factor? Medicine (Baltimore) 2017;96:e9441. [PMID: 29390576 DOI: 10.1097/MD.0000000000009441] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Sato S, Kunisaki C, Suematsu H, Tanaka Y, Miyamoto H, Kosaka T, Yukawa N, Tanaka K, Sato K, Akiyama H, Endo I. Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy. In Vivo 2018;32:603-10. [PMID: 29695567 DOI: 10.21873/invivo.11282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ferrat E, Audureau E, Paillaud E, Liuu E, Tournigand C, Lagrange JL, Canoui-Poitrine F, Caillet P, Bastuji-Garin S; ELCAPA Study Group. Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort. J Gerontol A Biol Sci Med Sci 2016;71:1653-60. [PMID: 27006079 DOI: 10.1093/gerona/glw052] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
26 Zhao L, Chi F, Xi M, Shen JX, Li QQ, He LR, Liu SL, Liu MZ. Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma. Biomed Pharmacother 2015;74:148-52. [PMID: 26349977 DOI: 10.1016/j.biopha.2015.08.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Kim DE, Kim UJ, Choi WY, Kim MY, Kim SH, Kim MJ, Shim HJ, Hwang JE, Bae WK, Chung IJ, Nam TK, Na KJ, Cho SH. Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy. Cancer Res Treat 2013;45:276-84. [PMID: 24454000 DOI: 10.4143/crt.2013.45.4.276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Hurmuzlu M, Monge OR, Smaaland R, Viste A. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome. Dis Esophagus 2010;23:244-52. [PMID: 19664075 DOI: 10.1111/j.1442-2050.2009.00999.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
29 Zhao Z, Wen Y, Liao D, Miao J, Gui Y, Cai H, Chen Y, Wei M, Jia Q, Tian H, Sun M, Zhang Y, Feng G, Du X. Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial. Oncologist 2020;25:e1900-8. [PMID: 32864805 DOI: 10.1634/theoncologist.2020-0808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Wada Y, Anbai A, Takagi N, Kumagai S, Okuyama E, Nanjo H, Sato Y, Motoyama S, Hashimoto M. Outcomes of Definitive Chemoradiotherapy for Stage IVa (T4b vs. N4) Esophageal Squamous Cell Carcinoma Based on the Japanese Classification System: A Retrospective Single-Center Study. Cancers (Basel) 2020;13:E8. [PMID: 33375169 DOI: 10.3390/cancers13010008] [Reference Citation Analysis]
31 Xu HY, DU ZD, Zhou L, Yu M, Ding ZY, Lu Y. Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma. Oncol Lett 2014;7:260-6. [PMID: 24348860 DOI: 10.3892/ol.2013.1694] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
32 Hassen HY, Teka MA, Addisse A. Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort Study. Front Oncol 2020;10:594342. [PMID: 33659206 DOI: 10.3389/fonc.2020.594342] [Reference Citation Analysis]
33 Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25:1824-1831. [PMID: 17488980 DOI: 10.1200/jco.2007.10.6559] [Cited by in Crossref: 599] [Cited by in F6Publishing: 187] [Article Influence: 39.9] [Reference Citation Analysis]
34 Ma ZB, Guo GH, Niu Q, Shi N. Role of EZH2 polymorphisms in esophageal squamous cell carcinoma risk in Han Chinese population. Int J Mol Sci 2014;15:12688-97. [PMID: 25036033 DOI: 10.3390/ijms150712688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
35 Saito H, Ohta A, Abe E, Kaidu M, Shioi M, Nakano T, Oshikane T, Tanaka K, Maruyama K, Kushima N, Tanabe S, Utsunomiya S, Sasamoto R, Aoyama H. Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. Clin Transl Radiat Oncol 2018;9:12-7. [PMID: 29594245 DOI: 10.1016/j.ctro.2017.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
36 Sun Y, Zhang XL, Mao QF, Liu YH, Kong L, Li MH. Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients. Curr Oncol 2018;25:e423-9. [PMID: 30464693 DOI: 10.3747/co.25.3895] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. Cancer Sci. 2009;100:1591-1596. [PMID: 19552757 DOI: 10.1111/j.1349-7006.2009.01224.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
38 Kuo IY, Huang YL, Lin CY, Lin CH, Chang WL, Lai WW, Wang YC. SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes. J Biomed Sci 2019;26:20. [PMID: 30777052 DOI: 10.1186/s12929-019-0510-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
39 Tougeron D, Richer JP, Silvain C. Management of esophageal adenocarcinoma. J Visc Surg. 2011;148:e161-e170. [PMID: 21715236 DOI: 10.1016/j.jviscsurg.2011.05.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
40 Tessier W, Piessen G, Briez N, Boschetto A, Sergent G, Mariette C. Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. Surg Endosc 2013;27:633-41. [DOI: 10.1007/s00464-012-2506-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
41 Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D, Xi M, Zeng YX, Xie D, Liu MZ. Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma. Med Oncol 2012;29:2669-76. [PMID: 22167391 DOI: 10.1007/s12032-011-0133-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tougeron D, Scotté M, Hamidou H, Di Fiore F, Paillot B, Michot F, Michel P. Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: An alternative to surgery? J Surg Oncol 2012;105:761-6. [DOI: 10.1002/jso.22157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
43 Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, Terrell JE. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009;27:1969-75. [PMID: 19289626 DOI: 10.1200/JCO.2008.18.2188] [Cited by in Crossref: 93] [Cited by in F6Publishing: 54] [Article Influence: 7.2] [Reference Citation Analysis]
44 Chang W, Lai W, Kuo I, Lin C, Lu P, Sheu B, Wang Y. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. J Gastroenterol 2017;52:705-14. [DOI: 10.1007/s00535-016-1265-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
45 Bharat A, Crabtree T. Management of advanced-stage operable esophageal cancer. Surg Clin North Am 2012;92:1179-97. [PMID: 23026277 DOI: 10.1016/j.suc.2012.07.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
46 Tougeron D, Di Fiore F, Hamidou H, Rigal O, Paillot B, Michel P. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis. Oncology 2007;73:328-34. [PMID: 18497505 DOI: 10.1159/000134476] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
47 Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol 2010; 16(13): 1649-1654 [PMID: 20355244 DOI: 10.3748/wjg.v16.i13.1649] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 92] [Article Influence: 7.8] [Reference Citation Analysis]
48 Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2009;22:477-81. [PMID: 19703071 DOI: 10.1111/j.1442-2050.2008.00910.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
49 Suh DC, Powers CA, Barone JA, Shin H, Kwon J, Goodin S. Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting study. Res Social Adm Pharm 2010;6:246-56. [PMID: 20813337 DOI: 10.1016/j.sapharm.2009.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
50 Duclos A, Di Fiore F, Lecleire S, Michel P. Predictive and prognostic factors in patients with an esophageal carcinoma treated with chemoradiotherapy: the key role of nutritional parameters. Gastroenterol Clin Biol 2009;33:491-2. [PMID: 19473797 DOI: 10.1016/j.gcb.2009.02.041] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]